Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine

Authors:
Publisher website
Google Scholar
Abstract
Owing to species-specific differences in liver pathways, in vitro human liver models are utilized for elucidating mechanisms underlying disease pathogenesis, drug development, and regenerative medicine. To mitigate limitations with de-differentiated cultures, bioengineers have developed advanced techniques/platforms, including micropatterned cocultures, spheroids/organoids, bioprinting, and microfluidic devices, for perfusing cell cultures and liver slices. Such techniques improve mature functions and culture lifetime of primary and stem-cell human liver cells. Furthermore, bioengineered liver models display several features of liver diseases including infections with pathogens (e.g., malaria, hepatitis C/B viruses, Zika, dengue, yellow fever), alcoholic/nonalcoholic fatty liver disease, and cancer. Here, we discuss features of bioengineered human liver models, their uses for modeling aforementioned diseases, and how such models are being augmented/adapted for fabricating implantable human liver tissues for clinical therapy. Ultimately, continued advances in bioengineered human liver models have the potential to aid the development of novel, safe, and efficacious therapies for liver disease.
Funding Information
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (1R21AI147137-01)
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK115747-01A1)

This publication has 253 references indexed in Scilit: